Takeda Announces New Assignments of Directors and Appointment of Julie Kim as Representative Director, President and CEO

Contributed by: Business Wire

Logo

Tags

Biotechnology

Pharmaceutical

Health

Oncology

Takeda Pharmaceutical Company Limited

More Like This

Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026

Takeda Announces New Assignments of Directors

Takeda Announces New Assignments of Directors

Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting

Kyowa Kirin International Announces Appointment of Julie Dehaene-Puype as President for the Region

Takeda Announces Chief Financial Officer Succession

Kyowa Kirin Announces Proposed Appointment of Abdul Mullick to President and Chief Executive Officer, While Former CEO Masashi Miyamoto to Remain Chairman

Dentsu Announces New Global Management Structure